Human iPSC-Derived Cardiomyocytes for Investigation of Disease Mechanisms and Therapeutic Strategies in Inherited Arrhythmia Syndromes: Strengths and Limitations
Population
Human induced pluripotent stem cell-derived cardiomyocytes used for modeling inherited arrhythmia syndromes
Design
Review
Authors
Discussion
Loading...
Member takes
Implication
Caution is required when translating these preclinical models to bedside applications; leaves open the need for maturation.
Structured PICO
P
Population
Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) used for modeling inherited arrhythmia syndromes
hiPSC-CMs offer a promising platform for patient- and mutation-specific investigation of inherited arrhythmias, though their relative immaturity remains a key limitation.
Limitations
- relative immaturity of hiPSC-CMs compared to adult human CMs
Cite This Study
Casini et al. (2017) studied this question.